Mergers & Acquisitions

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE from Synergy Pharmaceuticals

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE from Synergy Pharmaceuticals PR Newswire MISSISSAUGA, ON, Feb. 28, 2018 A new differentiated treatment option for GI disorders Transaction broadens Cipher’s Canadian portfolio providing entry into rapidly growing market where innovative treatments are needed MISSISSAUGA, ON , Feb. […]

Stock Analysts

Buy 5 Low P/CF Stocks to Sail Through Market Volatility

The prevailing volatility in Wall Street has rattled even the most ardent of investors, who started taking stock of their portfolio, overlooking the impressive earnings display by corporates for a while. Nevertheless, the market for now seems to have somewhat settled trying to accommodate rising bond yields and a possible uptick in inflation, with the backdrop dominated by the latest tax reform and healthy economic growth. What’s the Optimum Strategy? […]